Filed pursuant to General Instruction II.L. of Form F-10
File Nos. 333-249132 and 333-249132-01
A copy of this preliminary prospectus supplement has been filed with the securities regulatory authorities in each of the provinces of Canada, and with the U.S. Securities and Exchange Commission pursuant to an effective U.S. registration statement, but has not yet become final for the purpose of the sale of securities. Information contained in this preliminary prospectus supplement may not be complete and may have to be amended. This prospectus supplement is not an offer to sell these securities and it is not soliciting an offer to buy these securities in any U.S. state where the offer or sale is not permitted.
No securities regulatory authority has expressed an opinion about these securities and it is an offence to claim otherwise.
This prospectus supplement together with the short form base shelf prospectus to which it relates dated October 6, 2020, as amended or supplemented, and each document incorporated by reference in the short form base shelf prospectus, as amended or supplemented, constitutes a public offering of these securities only in those jurisdictions where they may be lawfully offered for sale and therein only by persons permitted to sell such securities.
Information has been incorporated by reference in this prospectus supplement and the accompanying short form base shelf prospectus to which it relates, as amended or supplemented, from documents filed with securities commissions or similar authorities in Canada. Copies of the documents incorporated herein by reference may be obtained on request without charge from the office of the Corporate Secretary of the Company at Suite 300, Brookfield Place, 181 Bay Street, Toronto, Ontario, Canada, M5J 2T3, Telephone: (416) 363-9491, and are also available electronically at www.sedar.com.
SUBJECT TO COMPLETION, DATED JULY 21, 2021
PRELIMINARY PROSPECTUS SUPPLEMENT
(To a Short Form Base Shelf Prospectus Dated October 6, 2020)
| New Issue | | | July 21, 2021 | |
BROOKFIELD FINANCE I (UK) PLC
BROOKFIELD FINANCE INC.
US$ % Notes due , 2032
US$ 3.500% Notes due March 30, 2051
Fully and unconditionally guaranteed by Brookfield Asset Management Inc.
Brookfield Finance I (UK) plc (the “UK Issuer”) is offering US$ aggregate principal amount of % notes due , 2032 (the “2032 notes”) and Brookfield Finance Inc. (“BFI” and together with the UK Issuer, the “Issuers” and each an “Issuer”) is offering US$ aggregate principal amount of 3.500% notes due March 30, 2051 (the “2051 notes” and, together with the 2032 notes, the “notes”). The UK Issuer will pay interest on the 2032 notes each and . BFI will pay interest on the 2051 notes each March 30 and September 30. The UK Issuer will make the first interest payment on the 2032 notes on , 2022 (the “2032 notes first interest payment date”). BFI will make the next scheduled interest payment on the 2051 notes on September 30, 2021. Unless the applicable Issuer redeems the relevant notes earlier, the 2032 notes will mature on , 2032 and the 2051 notes will mature on March 30, 2051. The UK Issuer or BFI may redeem some or all of the 2032 notes or 2051 notes, respectively, at any time at the applicable Redemption Price (as defined herein). The UK Issuer or BFI will be required to make an offer to purchase the 2032 notes or the 2051 notes, respectively, at a price equal to 101% of their principal amount, plus accrued and unpaid interest to the date of repurchase upon the occurrence of a Change of Control Triggering Event (as defined herein) in respect of the 2032 notes or the 2051 notes, as applicable. The UK Issuer may also redeem all of the 2032 notes at any time in the event of certain Tax Law Changes (as defined herein). BFI may also redeem all of the 2051 notes at any time in the event that certain changes affecting Canadian income taxation occur. The notes will be fully and unconditionally guaranteed as to payment of principal, premium (if any) and interest and certain other amounts by Brookfield Asset Management Inc. (the “Company” and collectively with its direct and indirect subsidiaries, including the Issuers, “Brookfield”).
As described under “Use of Proceeds” herein, Brookfield intends to allocate an amount equal to the net proceeds from the sale of the 2032 notes to the financing and/or refinancing of recently completed and future energy efficient green buildings and renewable energy projects or purchases, including the development and redevelopment of such buildings and projects.
BFI currently has outstanding US$500,000,000 aggregate principal amount of the 2051 notes (the “original 2051 notes”). The 2051 notes offered hereby have the same terms as the original 2051 notes, except for the issue date, the issue price and the date of the first payment of interest thereon. The 2051 notes offered under this prospectus supplement will have the same CUSIP number as the original 2051 notes and will trade interchangeably with such notes immediately upon settlement. Upon closing of this offering, the aggregate principal amount of the 2051 notes, together with the original 2051 notes, and assuming all 2051 notes offered hereby are sold, will be US$ .
The 2032 notes are a new series of securities with no established trading market. The 2051 notes are not and will not be listed on a securities exchange or quotation system and consequently, there is no market through which the 2051 notes may be sold and purchasers may not be able to resell the 2051 notes purchased under this prospectus supplement. Application will be made by the UK Issuer to list the 2032 notes on the New York Stock Exchange (the “NYSE”) prior to the 2032 notes first interest payment date. Until such time as the 2032 notes are listed, there is no market through which the 2032 notes may be sold and purchasers may not be able to resell the 2032 notes purchased under this prospectus supplement. This may affect the pricing of the notes in the secondary market, the transparency and availability of trading prices, the liquidity of the notes and the extent of issuer regulation. See “Risk Factors”.
Investing in the notes involves risks. See “Risk Factors” beginning on page S-9. | | | Per 2032 Note | | | Total 2032 Notes | | | Per 2051 Note | | | Total 2051 Notes | |
Public Offering Price(1) | | | | | % | | | | | US$ | | | | | | | %(2) | | | | | US$ | (2) | | |
Underwriting Fees | | | | | % | | | | | US$ | | | | | | | % | | | | | US$ | | | |
Proceeds to BFI (before expenses) | | | | | % | | | | | US$ | | | | | | | % | | | | | US$ | | | |
(1)
The effective yield of the 2032 notes, if held to , 2032, will be %, and the effective yield of the 2051 notes, if held to March 30, 2051 will be %.
(2)
Plus accrued interest from and including March 30, 2021 to, but excluding, the date of delivery, in the amount of US$ . Accrued interest must be paid by the purchasers of the 2051 notes.
Interest on the 2032 notes will accrue from , 2021. Interest on the 2051 notes accrues from March 30, 2021. The offering prices of the notes will be payable in U.S. dollars.
The Company and BFI are Canadian issuers that are permitted, under a multijurisdictional disclosure system adopted by the United States and Canada, to prepare this prospectus supplement and the accompanying base shelf prospectus in accordance with Canadian disclosure requirements. Prospective investors should be aware that such requirements are different from those of the United States. The financial statements incorporated herein have been prepared in accordance with International Financial Reporting Standards as issued by the International Accounting Standards Board (“IFRS”) and are subject to Canadian auditing and auditor independence standards, and thus may not be comparable to financial statements of U.S. companies.
Prospective investors should be aware that the acquisition of the notes may have tax consequences in the United States, Canada and the United Kingdom. Such consequences for investors who are residents in Canada or the United Kingdom or are residents in, or citizens of, the United States may not be described fully in this prospectus supplement and the accompanying base shelf prospectus. Prospective investors should consult their own tax advisors with respect to their particular circumstances. Prospective investors should read the risk factors and tax discussion beginning on pages S-9 and S-24, respectively.
The enforcement by investors of civil liabilities under U.S. federal securities laws may be affected adversely by the fact that BFI and the Company are incorporated under the laws of the Province of Ontario and the UK Issuer is organized under the laws of England and Wales, that some or all of the Issuers’ and the Company’s officers and directors may be residents of Canada or the United Kingdom, that some or all of the underwriters or experts named in this prospectus supplement and the accompanying base shelf prospectus may be residents of Canada and that such persons and all or a substantial portion of Issuers’ and the Company’s assets may be located outside the United States.
THESE SECURITIES HAVE NOT BEEN APPROVED OR DISAPPROVED BY THE SECURITIES AND EXCHANGE COMMISSION (THE “SEC”), ANY U.S. STATE SECURITIES COMMISSION OR ANY CANADIAN SECURITIES REGULATORY AUTHORITY, NOR HAS THE SEC, ANY U.S. STATE SECURITIES COMMISSION OR ANY CANADIAN SECURITIES REGULATORY AUTHORITY PASSED UPON THE ACCURACY OR ADEQUACY OF THIS PROSPECTUS. ANY REPRESENTATION TO THE CONTRARY IS A CRIMINAL OFFENSE.
Deutsche Bank Securities Inc., HSBC Securities (USA) Inc., Wells Fargo Securities LLC, and SMBC Nikko Securities America Inc. (the “underwriters”), as principals, conditionally offer the notes, subject to prior sale, if, as and when issued by the Issuers and accepted by the underwriters in accordance with the conditions contained in the underwriting agreement referred to under “Underwriting”. This offering will be made in Canada by (i) HSBC Securities (Canada) Inc., a broker-dealer affiliate of HSBC Securities (USA) Inc. and (ii) Wells Fargo Securities Canada, Ltd., a broker-dealer affiliate of Wells Fargo Securities, LLC. Deutsche Bank Securities Inc. and SMBC Nikko Securities America Inc., whom we refer to in this prospectus supplement as underwriters, will not offer the notes offered hereby in Canada. In connection with this offering, the underwriters may over-allot or effect transactions which stabilize or maintain the market price of the notes at levels other than those which otherwise might prevail on the open market. Such transactions, if commenced, may be discontinued at any time. In certain circumstances, the underwriters may offer the notes at a price lower than stated above. See “Underwriting”.
Delivery of the notes, in book-entry form only, will be made through The Depository Trust Company on or about , 2021.
The UK Issuer’s head and registered office is at Level 25, One Canada Square, London, E14 5AA, United Kingdom. BFI’s head and registered office is at Brookfield Place, 181 Bay Street, Suite 300, P.O. Box 762, Toronto, Ontario M5J 2T3.
Joint Book-Running Managers
| Deutsche Bank Securities | | | HSBC | | | Wells Fargo Securities | | | SMBC Nikko | |